Two cures20 Feb 2021 17:11
Testing still required!
Medics in Israel have been given the go-ahead for a third trial of a relatively new drug after successfully testing the treatment on a number of severely ill Covid-19 patients, of which 90 per cent fully recovered within a week, according to multiple media reports.
The drug, Allocetra, aims to slow or halt an extreme overreaction of the immune system, a so-called cytokine storm. It often follows a coronavirus infection and is believed to be responsible for many Covid-related deaths as it regularly leads to organ failure.
Allocetra, first developed at the Research Center for Rheumatology and Internal Medicine (CRIM) at Jerusalem’s Hadassah Medical Centre, was tested on 21 patients, of which 19 showed significant improvements within days and were discharged after a week, according to Israel’s Channel13 in Israel..........
AND
..................Researchers at the Ichilov Hospital in Tel Aviv told Israeli’s KAN News network that out of 30 seriously ill Covid-patients that were treated with the drug, 29 showed a significant improvement within two days and all were released within three to five days.
The medication, called EXO-CD24, is a targeted drug that was reportedly developed as a cure for certain types of cancer.
EXO-CD24 is relatively inexpensive and must be given once a day for a period of five days. Similar to Allocetra, it fights the cytokine storm, a severe immune overreaction.
On Monday, Israeli Prime Minister Benjamin Netanyahu invited professor Nadir Arber, who leads the EXO-CD24 trials at the Ichilov Hospital in Tel Aviv, to his office and asked him about the “miracle drug.”
During the meeting, Netanyahu reportedly said: “If this succeeds, it will be huge, simply huge. This is of global significance.”
Sign In
Follow the stocks
